CONSTELLATION PHARMACEUTICALS INC: common_shares_outstanding
| Value | {"unit": "shares", "value": 41719039, "concept": "us-gaap:CommonStockSharesOutstanding"} |
|---|---|
| Period | (as of 2019-12-31) |
| Status | current |
| Entity | CONSTELLATION PHARMACEUTICALS INC |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T14:05:39.010737+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/4a1da062-bd23-4533-a046-08d921cf1330
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001564590-20-021953Retrieved: 2026-08-19T14:05:39.010737+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001434418/common-shares-outstanding/2019-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/4a1da062-bd23-4533-a046-08d921cf1330
History
- supersedes {"unit": "shares", "value": 25803135, "concept": "us-gaap:CommonStockSharesOutstanding"} (evidence 0001564590-20-009735)